See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.73▲ 1.83%
← AMER3 page
XStocksXray
Market X-Ray report · 23 October 2026

Americanas S.A. (AMER3)

B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026

Key indicators

Last closeBRL 6.630
52-week range3.370 – 7.890
Return, 1 month / 3 months+28.7% / +65.3%
Return, 1 year / 3 years+25.8% / −91.5%
TrendUptrend
RSI (14)65
Volatility (1 year)62.9%
Worst drawdown (1 year)-55.5%
Average daily value traded8.67M BRL
Dividend yield–

Market X-Ray price-based

55/ 100 · High confidence · ahead of 60% of stocks on this exchange
Trend64
Momentum67
Stability (higher is calmer)16
Liquidity86
Income–

Five-year price chart navy: price · brown: 200-day average

-229.348561,9403,0254,1102021-102023-012024-042025-072026-10

About the company

Americanas is a Brazilian retailer that serves consumers through both physical stores and online channels. Its shops and digital marketplace offer a wide range of goods, including electronics, household items, food, toys and clothing, along with services such as payments and delivery. The company is based in Rio de Janeiro and reaches customers across Brazil through its store network and its internet platforms.

The shares are listed on the B3 Stock Exchange in Brazil under the code AMER3, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Americanas S.A. (AMER3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 6.630 on 23 October 2026.

Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 586 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 25.8% and over the last three months it rose 65.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Americanas S.A. (AMER3)

The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange

Lens and metricValueScoreReading
Trend64 · FairMixed trend against its averages.
Above 200-day average30.9%
From 52-week high-12.9%
Momentum67 · FairTypical recent returns for this exchange.
3-month return65.3%
6-month return10.1%
12-month return, skipping the last month-2.3%
Stability (higher is calmer)16 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)62.9%
Worst drawdown, 1 year (smaller is calmer)-55.5%
Liquidity86 · StrongTrades actively.
Average daily value traded8.67M BRL
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends1

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+18.8%
1 month+28.7%
3 months+65.3%
6 months+10.1%
1 year+25.8%
3 years−91.5%
5 years−99.8%

Signals

50-day / 200-day average5.050 / 5.067
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.425

Technical summary

DailyStrongly bullish12 bullish · 1 neutral · 3 bearish
WeeklyStrongly bullish9 bullish · 1 neutral · 2 bearish
MonthlyBullish5 bullish · 0 neutral · 3 bearish

Recent dividends

Ex-dividend dateAmount per share
31 Jan 2022BRL 0.6210

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026